Evidence map›Paper›PMID 14647396›Full record

ArticleMolecular psychiatry2003

Antipsychotic drug treatment alters expression of mRNAs encoding lipid metabolism-related proteins.

E A Thomas, R C George, P E Danielson, P A Nelson, A J Warren, D Lo, J G Sutcliffe

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular psychiatry, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 1 pooled it
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 1 synthesis or guideline pooled it, 61 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Inference of modules associated to eQTLs.Nucleic acids research · 2012
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

E A Thomas1Department of Molecular Biology, The Scripps Research Institute, La Jolla, CA, USA.
R C George
P E Danielson
P A Nelson
A J Warren
D Lo
J G Sutcliffe
Scripps Research Institute · USMarker Gene Technologies (United States) · US

Funding

GENE EXPRESSION IN RAT BRAINR01GM032355 · NIGMS · SCRIPPS RESEARCH INSTITUTE, THE · PI SUTCLIFFE, J GREGOR · 1985 to 2010
$4.2M
Towards Mechanistic Explanations of Striatal DisordersR01NS044169 · NINDS · SCRIPPS RESEARCH INSTITUTE, THE · PI THOMAS, ELIZABETH A · 2002 to 2010
$2.4M
NIGMS NIH HHS GM32355NINDS NIH HHS NS44169
6 · The paper itself

Abstract

Using an automated PCR-based genomics approach, TOtal Gene expression Analysis (TOGA), we have examined gene expression profiles of mouse striatum and frontal cortex in response to clozapine and haloperidol drug treatment. Of 17 315 mRNAs observed, TOGA identified several groups of related molecules that were regulated by drug treatment. The expression of some genes encoding proteins involved in neurotransmission, signal transduction, oxidative stress, cell adhesion, apoptosis and proteolysis were altered in the brains of both clozapine- and haloperidol-treated mice as recognized by TOGA. Most notable was the differential expression of those genes whose products are associated with lipid metabolism. These include apolipoprotein D (apoD), the mouse homolog of oxysterol-binding protein-like protein 8 (OSBPL8), a diacylglycerol receptor (n-chimerin), and lysophosphatidic acid (LPA) acyltransferase. Real-time PCR analysis confirmed increases in the RNA expression of apoD (1.6-2.2-fold) and OSBPL8 (1.7-2.6-fold), and decreases in the RNA expression of n-chimerin (1.5-2.2-fold) and LPA acyltransferase (1.5-fold) in response to haloperidol and/or clozapine treatment. Additional molecules related to calcium homeostasis and signal transduction, as well as four sequences of previously unidentified mRNAs, were also confirmed by real-time PCR to be regulated by drug treatment. While antipsychotic drugs may affect several metabolic pathways, lipid metabolism/signaling pathways may be of particular importance in the mechanisms of antipsychotic drug action and in the pathophysiology of psychiatric disorders.

Indexed as

Lipid MetabolismAcyltransferasesAnimalsAntipsychotic AgentsApolipoproteinsApolipoproteins DChimerin 1ClozapineDNA PrimersGene Expression RegulationHaloperidolMaleMiceMice, Inbred C57BLOxysterol Binding ProteinsPolymerase Chain Reaction2-acylglycerophosphate acyltransferaseAcyltransferasesAntipsychotic AgentsApolipoproteinsApolipoproteins DChimerin 1ClozapineDNA PrimersHaloperidolOxysterol Binding ProteinsReceptors, SteroidRNA, Messenger

Identifiers

PMID14647396
OpenAlexW2015225493

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.